Table 1.

Patients’ characteristics

Characteristics	n	%
Age, median (range), y	75 (62-85)	—
Sex
Male	22	67
Female	11	33
WHO performance status
0-1	23	70
2-3	10	30
Diagnosis
De novo	16	48
Secondary MDS	17	52
Karyotype
Intermediate	18	56
Unfavorable	13	39
Not evaluable	2	6
Laboratory median data (range)
Hb, g/dL	9.4 (7,6-12.3)	—
WBC, ×109/L	3.05 (0.26-24.53)	—
PLT, ×109/L	69 (6-260)	—
Blasts, %	60 (16-96)	—